The Effect of Real-time Continuous Glucose Monitoring on Severe Complications to Pregnancy in Women With Diabetes
1 other identifier
interventional
154
0 countries
N/A
Brief Summary
The purpose of the study is to investigate the effects of Real-time Continuous Glucose Monitoring on severe complications to pregnancy in women with diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes
Started Feb 2009
Typical duration for not_applicable diabetes
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 13, 2009
CompletedFirst Posted
Study publicly available on registry
October 14, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedMay 9, 2012
May 1, 2012
2.7 years
October 13, 2009
May 8, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of LGA in children of diabetic women.
Obtained shortly after birth
Secondary Outcomes (4)
Metabolic control in terms of HbA1c, blood sugar measurements and the occurence of severe hypoglycemia in pregnant diabetic patients.
During pregnancy
Quality of life, locus of control and anxiety and depression scores in pregnant diabetic patients.
During pregnancy
Neonatal disease such as neonatal hypoglycemia, respiratory distress and the occurrence of malformations in children of diabetic mothers.
Shortly after birth
The occurrence of low grade inflammation and endothelial dysfunction in pregnant women with diabetes.
During pregnancy
Study Arms (2)
Real-time Continuous Glucose Monitoring
EXPERIMENTALReal-time Continuous Glucose Monitoring at five times for up to 6 days during pregnancy, and during delivery, in addition to standard monitoring and treatment.
Control group
ACTIVE COMPARATORStandard monitoring and treatment of diabetic patients during pregnancy.
Interventions
Eligibility Criteria
You may qualify if:
- Pregestational diabetes, type 1 or type 2
- Single intrauterine pregnancy
- At least 18 years old
- Informed consent
You may not qualify if:
- Mental disorders
- Language barriere
- Gemelli
- Diabetic nephropathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Cordua S, Secher AL, Ringholm L, Damm P, Mathiesen ER. Real-time continuous glucose monitoring during labour and delivery in women with Type 1 diabetes - observations from a randomized controlled trial. Diabet Med. 2013 Nov;30(11):1374-81. doi: 10.1111/dme.12246. Epub 2013 Jul 26.
PMID: 23758126DERIVEDSecher AL, Ringholm L, Andersen HU, Damm P, Mathiesen ER. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care. 2013 Jul;36(7):1877-83. doi: 10.2337/dc12-2360. Epub 2013 Jan 24.
PMID: 23349548DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Elisabeth R Mathiesen, M.D.
Center for Pregnant Women with Diabetes, Copenhagen University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
October 13, 2009
First Posted
October 14, 2009
Study Start
February 1, 2009
Primary Completion
October 1, 2011
Study Completion
May 1, 2012
Last Updated
May 9, 2012
Record last verified: 2012-05